$26.97
0.923.53%
At Close: -
$26.96
-0.0100-0.04%
After Hours: Aug 23, 4:29 PM EDT
15 minutes delayed
ARK Genomic Revolution ETF (BATS: ARKG)
Ticker | Name | Share % | |
---|---|---|---|
TWST | Twist Bioscience Corp. | 9.60% | |
CDNA | Caredx | 7.29% | |
SM | Crispr Therapeutics Ag | 6.91% | |
RXRX | Recursion Pharmaceuticals, Inc. | 5.02% | |
IONS | Ionis Pharmaceuticals Inc | 4.88% | |
NTLA | Intellia Therapeutics | 4.74% | |
BEAM | Beam Therapeutics Inc | 4.41% | |
SDGR | Schrodinger, Inc. | 3.87% | |
ADPT | Adaptive Biotechnologies Corporation | 3.78% | |
TXG | 10X Genomics Inc | 3.61% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
ARKG follows a Small Cap Growth investment style.
The top holdings of ARKG include: TWST (9.6%), CDNA (7.29%), SM (6.91%), RXRX (5.02%), IONS (4.88%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for ARKG is currently not available.